SIBN — what changed in the latest 10-Q

Text added vs the prior filing · source: 10-Q · 2026-08-04

• Gross Profit and Gross Margin. Gross profit increased $5.7 million for the three months ended June 30, 2026 as compared to the three months ended June 30, 2025, mainly driven by higher revenue. The gross margin was 79.5% for the three months ended June 30, 2026 compared to a gross margin of 79.8% fo…

• Revenue, Cost of Goods Sold, Gross Profit, and Gross Margin:

• We derive the majority of our revenue from sales to customers in the U.S. Revenue by geography is based on billing address of the customer. The table below summarizes our revenue by geography:

• Revenue. The increase in revenue for the six months ended June 30, 2026 as compared to the six months ended June 30, 2025 was primarily driven by an $11.3 million increase in U.S. revenue driven by 12.3% increase in procedure volumes, supported by expanded adoption of our product portfolio, increase…

• Gross Profit and Gross Margin. Gross profit increased $10.0 million for the six months ended June 30, 2026 as compared to the six months ended June 30, 2025, mainly driven by higher revenue. The gross margin was 79.6% for the six months ended June 30, 2026 as compared to 79.8% for the six months end…

Text removed vs the prior filing · source: 10-Q · 2026-05-11

• Comparison of the Three Months Ended March 31, 2026 and 2025

• Gross Profit and Gross Margin. Gross profit increased $4.2 million for the three months ended March 31, 2026 as compared to the three months ended March 31, 2025, mainly driven by higher revenue. The gross margin remained stable year-over-year, reflecting lower product costs partially offset by high…

• As of March 31, 2026, we had cash and marketable securities of $144.7 million as compared to $147.8 million as of December 31, 2025. We have financed our operations primarily through our public offerings and debt financing arrangements. As of both March 31, 2026 and December 31, 2025, we had $35.6 m…

• As of March 31, 2026, we had an accumulated deficit of $454.6 million as compared to $450.3 million as of December 31, 2025. During the three months ended March 31, 2026, we incurred a net loss of $4.3 million. During the years ended December 31, 2025 and 2024, we incurred a net loss of $18.9 millio…

• Based upon our current operating plan, we believe that our existing cash and marketable securities will enable us to fund our operating expenses and capital expenditure requirements over the next 12 months from the filing of this Form 10-Q. However, the financial impact of a potential economic downt…

Text added vs the prior filing · source: 10-Q · 2026-08-04

• The information regarding legal proceedings set forth under “Legal Contingencies” in Note 6, Commitments and Contingencies, to our unaudited condensed consolidated financial statements included in Part I, Item 1 of this Quarterly Report on Form 10-Q is incorporated herein by reference.

Text removed vs the prior filing · source: 10-Q · 2026-05-11

• We are involved in various claims, complaints, investigations and legal actions that arise from time to time in the normal course of business, including commercial and employment matters. There are no matters pending that we currently believe are material. There can be no assurance that existing or …

Text added vs the prior filing · source: 10-Q · 2026-08-04

• During the fiscal quarter ended June 30, 2026, the following officer (as defined in Rule 16a-1(f) under the Exchange Act) adopted, modified or terminated a “Rule 10b5-1 trading arrangement” (as defined in Item 408 of Regulation S-K of the Exchange Act) as set forth in the table below.

• ActionAdoption/Termination DateRule 10b5-1*Non-Rule 10b5-1**Total Shares of Common Stock to be SoldTotal Shares of Common Stock to be PurchasedExpiration Date

• *Contract, instruction or written plan intended to satisfy the affirmative defense conditions of Rule 10b5-1(c) under the Exchange Act

• ** “Non-Rule 10b5-1 trading arrangement” as defined in Item 408(c) of Regulation S-K under the Exchange Act.

• (1) (a) up to 192,884 shares of common stock held by The David & Laura Joint Rev Tr; (b) up to 300,077 shares of common stock subject to performance-based restricted stock unit awards (“PSUs”) previously granted to Ms. Francis that may vest and be released to her on or before August 15, 2027 upon sa…

Text removed vs the prior filing · source: 10-Q · 2026-05-11

• During the fiscal quarter ended March 31, 2026, no director or Section 16 officer adopted, amended or terminated any Rule 10b5-1 trading arrangement or non-Rule 10b5-1 trading arrangement (in each case, as defined in Item 408(a) of Regulation S-K).